Citigroup’s ProPhase Labs PRPH Stock Holding History

Citigroup’s Portfolio PRPH Stock Details PRPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,947	Closed	-$23.3K	–	6268
2025 Q2	$23.3K	Buy	+5,947	New	+$19.9K	﹤0.01%	5039
2023 Q1	–	Sell	-1,535	Closed	-$148K	–	5781
2022 Q4	$148K	Buy	+1,535	New	+$166K	﹤0.01%	3864
2022 Q3	–	Sell	-72	Closed	-$9K	–	6218
2022 Q2	$9K	Buy	+72	New	+$6.33K	﹤0.01%	5409
2015 Q3	–	Sell	-2	Closed	–	–	7635
2015 Q2	$0	Buy	+2	New	+$27	﹤0.01%	7695
2013 Q4	–	Sell	-30	Closed	-$1K	–	7116
2013 Q3	$1K	Buy	+30	New	+$503	﹤0.01%	6686

Other funds holding PRPH

Sykon Capital Harrison, New York $325M AUM 19.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AWP

Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citigroup's PRPH Position: Q3 2025 in Review

Citigroup sold out of ProPhase Labs (PRPH) in Q3 2025, closing a stake of 5,947 shares — an estimated $23.3K sold.

Citigroup first reported a position in PRPH in Q3 2013 and held it in 5 quarters. The position peaked at $148K in Q4 2022. 28 funds tracked by Wall St. Rank hold PRPH as of Q3 2025.

Citigroup reported no remaining ProPhase Labs position as of Q3 2025 after selling out during the quarter.
Citigroup sold 5,947 ProPhase Labs shares in Q3 2025, an estimated $23.3K.
Citigroup first reported a position in ProPhase Labs in Q3 2013 and held it in 5 quarters.
Citigroup's ProPhase Labs position peaked at $148K in Q4 2022.
28 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2025.

Based on Citigroup's 13F filing for Q3 2025, filed 10 Nov 2025.